Agentic AI — systems that don’t just recommend an action but take it — is moving into healthcare faster than most organizations’ governance and workflow structures are ready for it. Prior authorization determinations, care coordination outreach, and claims triage are all live use cases now, not theoretical ones. The distinction that matters isn’t whether agentic AI works technically. It’s whether the process it’s being dropped into was actually well-defined enough to hand to a system that acts without a person reviewing every step.

Why agentic AI is a different risk category than earlier healthcare AI tools

Most healthcare AI deployed to date — ambient scribes, coding assistance, denial prediction — produces an output that a person reviews before it has consequences. A clinician reviews the drafted note. A biller reviews the coding suggestion. Agentic AI changes that structure by design: it’s meant to complete a task with less human review at each step, which means every implicit judgment call a person used to make along the way now has to be explicit in the process definition, or the agent either can’t act correctly on the edge cases or acts confidently on ones it shouldn’t.

This matters more in healthcare than in most industries because the “edge cases” are frequently the clinically or financially significant ones — the prior authorization request that doesn’t fit the standard criteria, the care coordination case with a complicating social factor, the claim that looks routine but has an unusual clinical justification. A process well-defined enough for a human to handle the standard 95% and improvise on the remaining 5% is not automatically well-defined enough for an agent to handle both.

Readiness is a process question before it’s a technology question

Recent research on agentic AI readiness in healthcare points to a consistent pattern: organizations furthest along aren’t the ones with the most advanced AI infrastructure — they’re the ones that did the harder work of clearly defining decision authority and escalation paths before deployment. For any process being considered for agentic AI, three questions determine actual readiness. Is the process well-documented enough that the edge cases are named, not just handled ad hoc by experienced staff? Is there a clear, fast escalation path when the agent encounters something outside its defined authority — and does the agent reliably recognize when it’s hit that boundary? And is the cost of the agent being wrong in this specific process low enough, and detectable fast enough, to make it a reasonable place to start?

Where to start, and where not to

The instinct is often to start agentic AI with the highest-value, highest-visibility process — full prior authorization determination, for instance. That’s usually the wrong place to start, precisely because it’s high-stakes and its edge cases are the ones with real clinical and financial consequences. A better starting point is a process that’s already well-documented, has a fast and low-friction escalation path, and where an error is both cheap and quickly caught — administrative scheduling coordination or routine eligibility verification, for example, rather than clinical determination.

That first deployment isn’t chosen because it’s impressive. It’s chosen because it will honestly answer whether the organization’s processes — not just its AI infrastructure — are ready for agentic systems, before that question gets asked on a process where the answer matters more.

SPAR scopes agentic AI deployments around process readiness first, technology second, because that ordering is what determines whether the deployment succeeds past the pilot. If you’re evaluating where to deploy agentic AI first, that scoping conversation is worth having before the build starts.